Is serum pepsinogen testing necessary in populationbased screening for gastric cancer?
Yeon-Ji Kim, Woo Chul Chung
Korean J Intern Med. 2020;35(3):544-546. Published online 2020 Apr 29 DOI: https://doi.org/10.3904/kjim.2020.139
Citations to this article as recorded by 
Value of serum G-17, PGI, PGII, Hp-IgG in the screening of gastric cancer and precancerous lesions and its relationship with the depth of tumor invasion
Qian Sheng, Guo-Dong Zhang, Min-Ya Wen
World Chinese Journal of Digestology.2022; 30(5): 235. CrossRef
Clinical Study of Serological Detection in Patients with Gastric Cancer
沛 郭
Medical Diagnosis.2022; 12(02): 201. CrossRef
Current Evidence for a Paradigm Shift in Gastric Cancer Prevention From Endoscopic Screening toHelicobacter pyloriEradication in Korea
Young-Il Kim, Il Ju Choi
Journal of Gastric Cancer.2022; 22(3): 169. CrossRef
Diagnostic performances of pepsinogens and gastrin-17 for atrophic gastritis and gastric cancer in Mongolian subjects
Ganchimeg Dondov, Dashmaa Amarbayasgalan, Batbold Batsaikhan, Tegshjargal Badamjav, Batchimeg Batbaatar, Baljinnyam Tuvdenjamts, Nasanjargal Tumurbat, Bayar Davaa, Erkhembulgan Purevdorj, Bayarmaa Nyamaa, Tulgaa Lonjid, Muhammad Tarek Abdel Ghafar
PLOS ONE.2022; 17(10): e0274938. CrossRef